首 页
医药产品
医保药品
中标目录
医药招标
数据中心
医学资料
医药新闻
医药展会
OTC药品
保健品
医疗器械
处方药
专科药
中医药
器械中标目录
药品批发行情
求购信息
医药下载
药价简讯
当前位置:药药网 / 数据中心 / 临床注释-2,变异和临床注释数据
别嘌醇
临床注释ID
1183701210
药物名称(英)
allopurinol
变异单倍型
HLA-A*33:03
基因
HLA-A
证据级别
2B
水平覆盖
水平修饰符
表现型类别(英)
Toxicity
表现型类别
毒性
分数
12.75
PMID计数
7
计数的证据
8
表现型
药物超敏反应;史蒂文斯-约翰逊综合征
表现型(英)
Drug Hypersensitivity;Stevens-Johnson Syndrome
最新日期
2021/3/24 0:00:00
URL
https://www.pharmgkb.org/clinicalAnnotation/1183701210
专业人口(英)
专业人口
临床等位基因
id
等位基因
注释文本
795
*33:03
Patients with one or two copies of the HLA-A*33:03 allele who are treated with allopurinol may have an increased risk of severe cutaneous adverse reactions (SCARs) as compared to patients with no HLA-A*33:03 alleles or negative for the HLA-A*33:03 test. This allele has been shown to be in linkage disequilibrium with the HLA-B*58:01 allele in some populations, which has a strong association with allopurinol-induced SCARs. Other genetic and clinical factors may also influence risk of allopurinol-induced adverse reactions.
临床证据
id
证据的ID
总结
2263
1184757286
HLA-A *33:01:01 is not associated with increased risk of erythema exudativum multiforme and Stevens-Johnson Syndrome when treated with allopurinol in people with Hyperuricemia.
2262
1184756788
HLA-A *33:03 is not associated with increased risk of Exanthema when treated with allopurinol in people with Kidney Failure, Chronic.
2261
1184756745
HLA-A *33:03 is associated with increased risk of severe cutaneous adverse reactions when treated with allopurinol in people with Kidney Failure, Chronic.
2260
1184755056
HLA-A *33:03 is associated with increased risk of severe cutaneous adverse reactions when treated with allopurinol.
2259
1184747209
HLA-A *33:03 is associated with increased risk of severe cutaneous adverse reactions when treated with allopurinol.
2258
1184467904
HLA-A *33:03:01 is associated with increased risk of severe cutaneous adverse reactions when treated with allopurinol.
2257
1183685091
HLA-A *33:01:01 is associated with Drug Hypersensitivity when treated with allopurinol in men.
2256
827919462
HLA-A *33:03 is associated with increased likelihood of Stevens-Johnson Syndrome or Epidermal Necrolysis, Toxic when treated with allopurinol in people with Drug Hypersensitivity.
临床病史
id
类型
评论
1176
Update
CA score added as part of scoring system release. LOE assigned following curator review.
1175
Update
Minor edits to phenotype descriptions
最新招商产品
更多>>
韩特润目冷敷凝胶贴牌定制代..
济南康民药业..
全国||不限
韩特润目冷敷凝胶贴牌定制代..
济南康民药业..
全国||不限
韩特乳康冷敷凝胶贴牌定制代..
济南康民药业..
全国||不限
韩特筋骨冷敷凝胶贴牌定制代..
济南康民药业..
全国||不限
韩特筋骨冷敷凝胶贴牌定制代..
济南康民药业..
全国||不限
韩特筋骨冷敷凝胶贴牌定制代..
济南康民药业..
全国||不限
韩特筋骨医用冷敷贴贴牌定制..
济南康民药业..
全国||不限
韩特筋骨医用冷敷贴贴牌定制..
济南康民药业..
全国||不限
韩特前列腺冷敷凝胶贴牌定制..
济南康民药业..
全国||不限
韩特前列腺医用冷敷贴贴牌定..
济南康民药业..
全国||不限
网站地图
-
网站开发
-
网站简介
-
会员服务
-
法律声明
-
联系我们
-
药品招商频道
-
药品信息排行
-
2018年版国家基本药物目录
-
意见反馈
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:
医药研究数据
|
医药资料
|
SDA药品评审中心
|
中医网
|
中药处方系统
|
爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究 客服热线:0575-83552251 / 13754370441 QQ客服:
浙ICP备16010490号-2
增值电信业务经营许可证:
浙B2-20220931
互联网药品信息服务资格证书编号:
(浙)-经营性2023-0215
浙公网安备:330683240604819103159
医药代理商群1:
医药代理商群2:
医药代理商群3: